The former category includes F8 gene mutations, single nucleotide polymorphisms at the HLA locus, mutations in the immunomodulatory gene, race and family history; the latter category includes the age of first exposure, treatment intensity, type of FVIII preparation, presence of infection and history of surgery (22). Here, F8 is linked to infection.